Galeflaprit fumarate
Galeflaprit (LXE408) fumarate is an orally active, non-competitive and kinetoplastid-selective proteasome inhibitor.Galeflaprit fumarate has an IC50 of 0.04 μM for L. donovani proteasome and an EC50 of 0.04 μM for L. donovani. Galeflaprit fumarate has a low propensity to cross the blood brain barrier. Galeflaprit fumarate has the potential for visceral leishmaniasis (VL) research.
For research use only. We do not sell to patients.
- CAS No.: 3026790-19-9
- Formula: C27H22FN7O6
- Molecular Weight:559.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Parasite Isoforms
More
Biological Activity
Description
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 3026790-19-9
-
Molecular Weight 559.51
-
Formula C27H22FN7O6
-
SMILES
O=C(C1=C(C)N=C(C)O1)NC2=CC=C(F)C(C3=NN4C=C(C5=NC=CC=C5C)C=NC4=N3)=C2.O=C(O)/C=C/C(O)=O
-
Synonyms
LXE408 fumarate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)